CTU2 mRNA levels increased with advancing clinical stage in cancers such as BRCA, HNSC, KIRC, KIRP, LIHC, LUSC, and testicular germ cell tumors (TGCT) (Figure 3D). The gene discussed is CTU2; the disease is cancer.